Literature DB >> 6090811

Development of plasma 21-deoxycortisol radioimmunoassay and application to the diagnosis of patients with 21-hydroxylase deficiency.

A Milewicz, P Vecsei, S Korth-Schütz, D Haack, A Rösler, K Lichtwald, S Lewicka, G von Mittelstaedt.   

Abstract

Specific 21-deoxycortisol (21-DF) antiserum was raised in New Zealand white rabbits using a 21-DF-3,20-oxime-bovine serum albumin complex. Plasma radioimmunoassay of 21-DF was developed and used together with a radioimmunoassay of 17-hydroxyprogesterone (17-OH-P) for diagnosis of patients with 21-hydroxylase deficiency of congenital and postpubertal forms. The assays were performed in plasma extracts after isolation by paper chromatography. The response of plasma 21-DF and 17-OH-P to i.v. ACTH (25 IU) was studied in 15 adult controls and compared to 8 women with the late onset form of 21-hydroxylase deficiency and 23 women with idiopathic hirsutism. Normal 21-DF values for women were 6.9 +/- 3.6 ng/dl and for men 9.71 +/- 2.73 ng/dl. Newborn children (age: 3-10 days) had a value of 8.3 +/- 4.8 ng/dl. These values are definitely lower than the lowest value ever published. This is possibly due to the specificity of the antibody. During the menstrual cycle the 21-DF values did not change. The baseline and post-stimulated concentrations of hormone were similar in controls and women with hirsutism but were significantly higher in women with the late onset form of 21-hydroxylase deficiency. In the congenital form of 21-hydroxylase deficiency the 21-DF values (baseline) were high. In general, the 21-DF and 17-OH-P values have shown parallel changes. However, one case of 21-hydroxylase deficiency with elevated 21-DF but normal 17-OH-P was observed. The use of 21-DF for the diagnosis of 21-hydroxylase deficiency is suggested.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090811     DOI: 10.1016/0022-4731(84)90382-0

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  10 in total

1.  Congenital adrenal hyperplasia due to combined 21- and 11 beta-hydroxylase deficiency.

Authors:  R Penny; P Vecsei
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

2.  Stimulation of gonadal steroid synthesis by chronic excess of adrenocorticotropin in patients with adrenocortical insufficiency.

Authors:  H Vierhapper; P Nowotny; W Waldhäusl
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

3.  Assessment of the one hour adrenocorticotrophic hormone test in the diagnosis of attenuated 21-hydroxylase deficiency.

Authors:  V T Innanen; J M Vale
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

4.  [Therapy of hirsutism in females with adrenal enzyme defects of steroid hormone biosynthesis: comparison of dexamethasone with cyproterone acetate].

Authors:  K Frank-Raue; G Junga; F Raue; P Vecsei; R Ziegler
Journal:  Klin Wochenschr       Date:  1990-06-19

5.  Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision).

Authors:  Tomohiro Ishii; Kenichi Kashimada; Naoko Amano; Kei Takasawa; Akari Nakamura-Utsunomiya; Shuichi Yatsuga; Tokuo Mukai; Shinobu Ida; Mitsuhisa Isobe; Masaru Fukushi; Hiroyuki Satoh; Kaoru Yoshino; Michio Otsuki; Takuyuki Katabami; Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2022-04-10

6.  Detection of late onset steroid 21-hydroxylase deficiency by capillary gas chromatographic profiling of urinary steroids in children and adolescents.

Authors:  J Homoki; J Solyom; W M Teller
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

Review 7.  Steroid biomarkers in human adrenal disease.

Authors:  Juilee Rege; Adina F Turcu; Tobias Else; Richard J Auchus; William E Rainey
Journal:  J Steroid Biochem Mol Biol       Date:  2019-01-29       Impact factor: 4.292

Review 8.  Steroid assays in paediatric endocrinology.

Authors:  John W Honour
Journal:  J Clin Res Pediatr Endocrinol       Date:  2010-02-01

9.  Analysis of a pitfall in congenital adrenal hyperplasia newborn screening: evidence of maternal use of corticoids detected on dried blood spot.

Authors:  Muriel Houang; Thao Nguyen-Khoa; Thibaut Eguether; Bettina Ribault; Séverine Brabant; Michel Polak; Irène Netchine; Antonin Lamazière
Journal:  Endocr Connect       Date:  2022-06-15       Impact factor: 3.221

10.  A Liquid Chromatography/Tandem Mass Spectometry Profile of 16 Serum Steroids, Including 21-Deoxycortisol and 21-Deoxycorticosterone, for Management of Congenital Adrenal Hyperplasia.

Authors:  Jean Fiet; Yves Le Bouc; Jérôme Guéchot; Nicolas Hélin; Marie-Anne Maubert; Dominique Farabos; Antonin Lamazière
Journal:  J Endocr Soc       Date:  2017-02-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.